Direktorat Registrasi ObatValid

XTANDI

BPOM Number: DKI2520100817B1
Approved: 31 December 2025
Expiry: 30 December 2030
Form: TABLET SALUT SELAPUT

About This Registration

XTANDI is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2520100817B1. Its current registration status is Valid, with the licence valid until 30 December 2030. The product is registered to MEPROFARM and manufactured by MEPROFARM - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 4 AMPLOP @ 1 BLISTER @ 14 TABLET SALUT SELAPUT (56 TABLET SALUT SELAPUT)
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MEPROFARM
Kota Bandung, Jawa Barat, Indonesia
NPWP: 011310331441000
owner
View profile →

Manufacturing Sites

MEPROFARM - INDONESIA
KOTA BANDUNG
primary
View profile →

Ingredients (1)

ENZALUTAMIDE

Market Intelligence

Owner Portfolio: MEPROFARM holds 287 BPOM registrations
Manufacturer Scale: MEPROFARM - INDONESIA produces 281 registered products
Registration Age: Registered for 6 months

FDA Cross-Reference

via openFDA

Generic Name: ENZALUTAMIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?